Evaluation of the Effect of Harmaline on the Serum Level of Liver Index Enzymes in a Model of Non-alcoholic Fatty Liver of Male NMRI Mice

Subject Areas : Journal of Animal Biology

Tannaz Kowsari Moghadam ¹ , Hanieh Jafary ² , Parichehreh Yaghmaei ³

1 - Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2 - Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
3 - Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

Received: 2020-03-25 Accepted : 2021-05-08 Published : 2021-11-22

Keywords: Antioxidant, Harmaline, Liver Enzyme, Nonalcoholic Fatty Liver,

Abstract :

Right now, one of the most common liver disorders is fatty liver, on the rise in the world today due to the poor lifestyle of those suffering from it. The aim of this study was to investigate the effect of the active ingredient of Peganum harmala, harmaline, on serum levels of liver index enzymes in mice with non-alcoholic fatty liver. In this study, 40 adult male NMRI mice were divided into five groups of 8, including control, HFD, sham (HFD received distilled water, a harmaline solvent.), harmaline receiving 50 mg/kg and 100 mg/kg. Harmaline was injected intraperitoneally for four weeks. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and lipid profile (cholesterol, LDL, and HDL) were measured to assess liver function. The activity of antioxidant enzymes such as catalase, glutathione peroxidase, and superoxide dismutase (SOD) in liver tissue were evaluated. Histological studies were performed using Hematoxylin-Eosin staining in liver tissue. Serum levels of ALT, AST, ALP, cholesterol, LDL were significantly decreased in the groups treated with harmaline and the levels of antioxidant enzymes catalase, glutathione peroxidase, and SOD were significantly increased in the treated groups. HDL levels increased significantly in harmaline-treated groups. The results indicated the antioxidant properties of harmaline, one of the most important alkaloids of Peganum harmala..

References:

1- Abedi G.F., Abedi G.Y., Moazenzade K.O., Mardomi A., Ghahremanzadeh K. 2015. Effects of a triplex mixture of Peganum harmala, Rhus coriaria, and Urtica dioica aqueous extracts on metabolic and histological parameters in diabetic rats. Pharmaceutical biology, 53(8): 1104-1109.

2- Abolhassanzadeh Z., Aflaki E., Yousefi G., Mohagheghzadeh A. 2015. Randomized clinical trial of peganum oil for knee osteoarthritis. Journal of evidence-based complementary & alternative medicine, 20(2): 126-131.

3- Behairy A., Abd El-Rahman G.I., Aly S.S.H, Fahmy E.M., Abd-Elhakim Y.M. 2021. Di(2-ethylhexyl) adipate plasticizer triggers hepatic, brain, and cardiac injury in rats: Mitigating effect of Peganum harmala oil. Ecotoxicology and environmental safety, 208: 111620.

4- Bensalem S., Soubhye J., Aldib I., Bournine L., Nguyen A.T. 2014. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae). Journal of ethnopharmacology, 154(2): 361-369.

5- Berrougui H., Isabelle M., Cloutier M., Hmamouchi M., Khalil A. 2006. Protective effects of Peganum harmala L. extract, harmine and harmaline against human low-density lipoprotein oxidation. The Journal of pharmacy and pharmacology, 58(7): 967-974.

6- Bourogaa E., Jarraya R.M, Damak M., Elfeki A. 2015. Hepatoprotective activity of Peganum harmala against ethanol-induced liver damages in rats. Archives of physiology and biochemistry, 121(2): 62-67.

7- Bremner P., Rivera D., Calzado M.A., Obon C., Inocencio C. 2009. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators. Journal of ethnopharmacology, 124(2): 295-305.

8- Chabir N., Ibrahim H., Romdhane H., Valentin A., Moukarzel B. 2014. Seeds of Peganum Harmala L. chemical analysis, antimalarial and antioxidant activities, and cytotoxicity against human breast cancer cells. Medicinal chemistry, 11(1): 94-101.

9- Daoud A., Song J., Xiao F., Shang J. 2014. A novel beta-carboline derivative exhibits anti-cancer activity via induction of apoptosis and inhibition of cell migration in vitro. European journal of pharmacology, 724: 219-230.

10- El Gendy M.A., Somayaji V., El-Kadi A.O. 2010. Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects. Planta medica, 76(7): 671-677.

11- Ghaffar S., Afridi S.K., Aftab M.F., Murtaza M., Syed S.A. 2016. Attenuation of palmitate induced insulin resistance in muscle cells by harmala, clove and river red gum. Pakistan journal of pharmaceutical sciences, 29(5): 1795-1800.

12- Hadadi Z., Nematzadeh G.A., Ghahari S. 2020. A study on the antioxidant and antimicrobial activities in the chloroformic and methanolic extracts of 6 important medicinal plants collected from North of Iran. BMC chemistry, 14(1): 33.

13- Hamsa T., Kuttan G. 2011. Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 30(2): 123-137.

14- Ibraheem Z.O., Abdul Majid R., Mohd Noor S., Mohd Sidek H., Basir R. 2015. The Potential of beta Carbolin Alkaloids to Hinder Growth and Reverse Chloroquine Resistance in Plasmodium falciparum. Iranian journal of parasitology, 10(4): 577-583.

15- Im J.H., Jin Y.R., Lee J.J., Yu J.Y., Han X.H. 2009. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation. Vascular pharmacology, 50(5-6): 147-152.

16- Jalali A., Dabaghian F., Zarshenas M.M. 2021. Alkaloids of Peganum harmala: Anticancer Biomarkers with Promising Outcomes. Current pharmaceutical design, 27(2): 185-196.

17- Karam M.A., Abd-Elgawad M.E., Ali R.M. 2016. Differential gene expression of salt-stressed Peganum harmala L. Journal, genetic engineering & biotechnology, 14(2): 319-326.

18- Lei Y.J., Xia Z.F., Luo X.X., Zhang L.L. 2020. Actinokineospora pegani sp. nov., an endophytic actinomycete isolated from the surface-sterilized root of Peganum harmala L. International journal of systematic and evolutionary microbiology, 70(7): 4358-4363.

19- Moshiri M., Etemad L., Javidi S., Alizadeh A. 2013. Peganum harmala intoxication, a case report. Avicenna journal of phytomedicine, 3(3): 288-292.

20- Panahi Y., Saadat A., Seifi M., Rajaee M., Butler A.E., Sahebkar A. 2018. Effects of Spinal-Z in Patients with Gastroesophageal Cancer. Journal of pharmacopuncture, 21(1): 26-34.

21- Rezaei M., Nasri S., Roughani M., Niknami Z., Ziai S.A. 2016. Peganum Harmala L. Extract Reduces Oxidative Stress and Improves Symptoms in 6-Hydroxydopamine-Induced Parkinson's Disease in Rats. Iranian journal of pharmaceutical research, 15(1): 275-281.

22- Singh A.B., Chaturvedi J.P., Narender T., Srivastava A.K. 2008. Preliminary studies on the hypoglycemic effect of Peganum harmala L. Seeds ethanol extract on normal and streptozotocin induced diabetic rats. Indian journal of clinical biochemistry, 23(4): 391-393.

23- Wang Y., Wang H., Zhang L., Zhang Y., Sheng Y. 2019. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats. Journal of ethnopharmacology, 238: 111866.

24- Zhang L., She Z., Li H. 2020. Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis. Clinical Science(Lon), 134(13): 1775-1799.